Concepts (165)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
| Dyspnea | 14 | 2020 | 3847 | 1.81 | Why? |
| Diaphragm | 4 | 2019 | 232 | 1.19 | Why? |
| Amyotrophic Lateral Sclerosis | 3 | 2019 | 398 | 1.12 | Why? |
| Sleep Apnea, Central | 3 | 2018 | 28 | 0.87 | Why? |
| Phrenic Nerve | 2 | 2018 | 37 | 0.71 | Why? |
| Sodium Potassium Chloride Symporter Inhibitors | 1 | 2017 | 49 | 0.70 | Why? |
| Hypoventilation | 2 | 2017 | 17 | 0.70 | Why? |
| Transcranial Magnetic Stimulation | 1 | 2018 | 160 | 0.66 | Why? |
| Furosemide | 1 | 2017 | 99 | 0.66 | Why? |
| Respiration | 6 | 2020 | 729 | 0.65 | Why? |
| Electric Stimulation Therapy | 1 | 2013 | 151 | 0.44 | Why? |
| Respiratory Muscles | 3 | 2019 | 116 | 0.36 | Why? |
| Fear | 2 | 2018 | 3607 | 0.31 | Why? |
| Pulmonary Disease, Chronic Obstructive | 3 | 2019 | 3832 | 0.31 | Why? |
| Hypertension, Pulmonary | 1 | 2013 | 970 | 0.26 | Why? |
| Vital Capacity | 2 | 2021 | 399 | 0.24 | Why? |
| Ecdysterone | 1 | 2021 | 17 | 0.23 | Why? |
| Respiratory Insufficiency | 3 | 2021 | 7301 | 0.22 | Why? |
| Brain | 1 | 2017 | 5133 | 0.20 | Why? |
| Hypercapnia | 2 | 2018 | 172 | 0.20 | Why? |
| Quality of Life | 3 | 2019 | 9820 | 0.19 | Why? |
| Terminally Ill | 1 | 2018 | 40 | 0.19 | Why? |
| Atrophy | 1 | 2019 | 192 | 0.18 | Why? |
| Motor Neuron Disease | 1 | 2018 | 45 | 0.18 | Why? |
| Forced Expiratory Volume | 1 | 2021 | 632 | 0.18 | Why? |
| Facial Expression | 1 | 2018 | 74 | 0.17 | Why? |
| Neural Conduction | 1 | 2018 | 261 | 0.16 | Why? |
| Electromyography | 1 | 2018 | 278 | 0.16 | Why? |
| Facial Recognition | 1 | 2018 | 75 | 0.16 | Why? |
| Chronic Disease | 4 | 2020 | 5139 | 0.16 | Why? |
| Body Image | 1 | 2017 | 96 | 0.16 | Why? |
| Home Care Services | 2 | 2018 | 1351 | 0.16 | Why? |
| Breathing Exercises | 1 | 2018 | 118 | 0.16 | Why? |
| Consciousness | 1 | 2017 | 140 | 0.15 | Why? |
| Awareness | 1 | 2020 | 529 | 0.15 | Why? |
| Analysis of Variance | 1 | 2018 | 950 | 0.14 | Why? |
| Noninvasive Ventilation | 2 | 2018 | 2329 | 0.14 | Why? |
| Administration, Inhalation | 2 | 2020 | 1647 | 0.14 | Why? |
| Tidal Volume | 1 | 2017 | 565 | 0.14 | Why? |
| Pain Measurement | 1 | 2017 | 533 | 0.14 | Why? |
| Neural Prostheses | 1 | 2013 | 1 | 0.14 | Why? |
| Cross-Over Studies | 1 | 2017 | 867 | 0.13 | Why? |
| Hypertrophy, Right Ventricular | 1 | 2013 | 33 | 0.13 | Why? |
| Shoulder Pain | 1 | 2013 | 36 | 0.13 | Why? |
| Stress, Physiological | 1 | 2017 | 378 | 0.13 | Why? |
| Familial Primary Pulmonary Hypertension | 1 | 2013 | 68 | 0.12 | Why? |
| Self Concept | 1 | 2017 | 490 | 0.12 | Why? |
| Ageusia | 1 | 2020 | 918 | 0.12 | Why? |
| Anxiety | 1 | 2018 | 17311 | 0.12 | Why? |
| Treatment Failure | 1 | 2018 | 2106 | 0.12 | Why? |
| Arterial Pressure | 1 | 2013 | 208 | 0.11 | Why? |
| Double-Blind Method | 2 | 2021 | 5988 | 0.10 | Why? |
| Respiration, Artificial | 5 | 2021 | 22116 | 0.10 | Why? |
| Pain | 1 | 2017 | 1084 | 0.10 | Why? |
| Analgesics, Opioid | 1 | 2019 | 1070 | 0.10 | Why? |
| Brain Diseases | 1 | 2021 | 1463 | 0.09 | Why? |
| Exercise Therapy | 1 | 2018 | 976 | 0.09 | Why? |
| Lupus Erythematosus, Systemic | 1 | 2020 | 1380 | 0.09 | Why? |
| Analgesics | 1 | 2013 | 451 | 0.09 | Why? |
| Killer Cells, Natural | 1 | 2017 | 2093 | 0.08 | Why? |
| Multivariate Analysis | 1 | 2018 | 5440 | 0.08 | Why? |
| Cough | 1 | 2020 | 4891 | 0.08 | Why? |
| Severity of Illness Index | 6 | 2021 | 48226 | 0.08 | Why? |
| Intubation, Intratracheal | 2 | 2020 | 3962 | 0.08 | Why? |
| Pulmonary Artery | 1 | 2013 | 803 | 0.08 | Why? |
| Proportional Hazards Models | 1 | 2018 | 6543 | 0.08 | Why? |
| Ventilators, Mechanical | 1 | 2017 | 2193 | 0.07 | Why? |
| Humans | 29 | 2021 | 930598 | 0.07 | Why? |
| Prospective Studies | 3 | 2019 | 43301 | 0.07 | Why? |
| Female | 16 | 2021 | 380317 | 0.07 | Why? |
| Survival Analysis | 1 | 2018 | 7592 | 0.07 | Why? |
| Respiratory Function Tests | 3 | 2021 | 1755 | 0.07 | Why? |
| Chronic Pain | 1 | 2013 | 736 | 0.07 | Why? |
| Sleep | 1 | 2017 | 2695 | 0.07 | Why? |
| Patient Selection | 1 | 2018 | 4560 | 0.07 | Why? |
| Male | 16 | 2021 | 367725 | 0.07 | Why? |
| France | 4 | 2021 | 12074 | 0.06 | Why? |
| Longitudinal Studies | 1 | 2018 | 9893 | 0.06 | Why? |
| Treatment Outcome | 4 | 2021 | 51732 | 0.06 | Why? |
| Palliative Care | 1 | 2017 | 2665 | 0.06 | Why? |
| Carbon Dioxide | 2 | 2020 | 917 | 0.06 | Why? |
| Lung | 2 | 2021 | 31049 | 0.06 | Why? |
| Healthy Volunteers | 2 | 2018 | 1444 | 0.06 | Why? |
| Middle Aged | 11 | 2021 | 270681 | 0.06 | Why? |
| Time Factors | 4 | 2021 | 31397 | 0.06 | Why? |
| Bronchial Hyperreactivity | 1 | 2020 | 38 | 0.06 | Why? |
| Aerosols | 1 | 2017 | 5393 | 0.05 | Why? |
| Aged | 8 | 2021 | 215776 | 0.05 | Why? |
| Tachypnea | 1 | 2021 | 197 | 0.05 | Why? |
| Stroop Test | 1 | 2018 | 7 | 0.05 | Why? |
| Proto-Oncogene Proteins | 1 | 2021 | 340 | 0.05 | Why? |
| Inspiratory Capacity | 1 | 2018 | 47 | 0.05 | Why? |
| Pulmonologists | 1 | 2019 | 98 | 0.05 | Why? |
| Prognosis | 2 | 2020 | 32490 | 0.04 | Why? |
| Cohort Studies | 2 | 2021 | 36005 | 0.04 | Why? |
| Electrodes | 1 | 2019 | 203 | 0.04 | Why? |
| Photic Stimulation | 1 | 2017 | 74 | 0.04 | Why? |
| Masks | 1 | 2020 | 8528 | 0.04 | Why? |
| Receptors, G-Protein-Coupled | 1 | 2021 | 309 | 0.04 | Why? |
| Exercise | 1 | 2017 | 6771 | 0.04 | Why? |
| Respiratory Mechanics | 1 | 2001 | 585 | 0.04 | Why? |
| Oxygen Inhalation Therapy | 2 | 2021 | 3629 | 0.04 | Why? |
| Calibration | 1 | 2017 | 307 | 0.04 | Why? |
| Nebulizers and Vaporizers | 1 | 2020 | 497 | 0.04 | Why? |
| Equipment Failure | 1 | 2018 | 197 | 0.04 | Why? |
| Hydroxychloroquine | 1 | 2020 | 12447 | 0.04 | Why? |
| Delphi Technique | 1 | 2020 | 1257 | 0.04 | Why? |
| Problem-Based Learning | 1 | 2020 | 363 | 0.04 | Why? |
| Hypoxia | 2 | 2021 | 3626 | 0.04 | Why? |
| Muscle Weakness | 1 | 2019 | 406 | 0.04 | Why? |
| Outpatient Clinics, Hospital | 1 | 2020 | 523 | 0.04 | Why? |
| Walk Test | 1 | 2018 | 461 | 0.04 | Why? |
| Risk Assessment | 1 | 2018 | 25439 | 0.03 | Why? |
| Single-Blind Method | 1 | 2018 | 1283 | 0.03 | Why? |
| Electroencephalography | 1 | 2021 | 1242 | 0.03 | Why? |
| Critical Care | 1 | 2017 | 14081 | 0.03 | Why? |
| Respiratory Therapy | 1 | 2020 | 918 | 0.03 | Why? |
| Adipose Tissue | 1 | 2019 | 612 | 0.03 | Why? |
| Switzerland | 1 | 2020 | 2738 | 0.03 | Why? |
| Adult | 8 | 2020 | 244371 | 0.03 | Why? |
| Continuous Positive Airway Pressure | 1 | 2020 | 1187 | 0.03 | Why? |
| Regression Analysis | 1 | 2019 | 2484 | 0.03 | Why? |
| Randomized Controlled Trials as Topic | 2 | 2021 | 10649 | 0.03 | Why? |
| Coronavirus | 1 | 2020 | 18339 | 0.03 | Why? |
| Protein Kinase Inhibitors | 1 | 2020 | 1585 | 0.03 | Why? |
| Biopsy | 1 | 2019 | 2811 | 0.02 | Why? |
| Self Care | 1 | 2018 | 918 | 0.02 | Why? |
| Case-Control Studies | 2 | 2020 | 17671 | 0.02 | Why? |
| Prevalence | 2 | 2020 | 25773 | 0.02 | Why? |
| Electronic Health Records | 1 | 2021 | 3492 | 0.02 | Why? |
| Self Report | 1 | 2018 | 3802 | 0.02 | Why? |
| Patient Care Team | 1 | 2020 | 3556 | 0.02 | Why? |
| Hospitalization | 3 | 2021 | 54280 | 0.02 | Why? |
| Renin-Angiotensin System | 1 | 2021 | 3661 | 0.02 | Why? |
| Glucocorticoids | 1 | 2020 | 4431 | 0.02 | Why? |
| Stress Disorders, Post-Traumatic | 1 | 2020 | 2963 | 0.02 | Why? |
| Radiography, Thoracic | 1 | 2021 | 5486 | 0.02 | Why? |
| Magnetic Resonance Imaging | 1 | 2021 | 6551 | 0.02 | Why? |
| Tomography, X-Ray Computed | 2 | 2021 | 25144 | 0.02 | Why? |
| Mortality | 1 | 2021 | 7132 | 0.02 | Why? |
| Ambulatory Care | 1 | 2020 | 4947 | 0.02 | Why? |
| Ultrasonography | 1 | 2019 | 4409 | 0.02 | Why? |
| Abdominal Muscles | 1 | 2001 | 26 | 0.01 | Why? |
| Young Adult | 3 | 2018 | 93724 | 0.01 | Why? |
| Primary Health Care | 1 | 2020 | 4839 | 0.01 | Why? |
| Extracorporeal Membrane Oxygenation | 1 | 2021 | 5002 | 0.01 | Why? |
| Disease Progression | 1 | 2021 | 13580 | 0.01 | Why? |
| Pneumonia, Viral | 2 | 2020 | 243684 | 0.01 | Why? |
| Coronavirus Infections | 2 | 2020 | 253789 | 0.01 | Why? |
| Tertiary Care Centers | 1 | 2019 | 8248 | 0.01 | Why? |
| Stomach | 1 | 2001 | 141 | 0.01 | Why? |
| Communication | 1 | 2018 | 5206 | 0.01 | Why? |
| Practice Patterns, Physicians' | 1 | 2019 | 4927 | 0.01 | Why? |
| Esophagus | 1 | 2001 | 139 | 0.01 | Why? |
| Pressure | 1 | 2001 | 289 | 0.01 | Why? |
| Retrospective Studies | 2 | 2021 | 105322 | 0.01 | Why? |
| Pandemics | 2 | 2020 | 389249 | 0.01 | Why? |
| China | 1 | 2020 | 50654 | 0.01 | Why? |
| Cross-Sectional Studies | 1 | 2020 | 53120 | 0.01 | Why? |
| Surveys and Questionnaires | 1 | 2019 | 43792 | 0.01 | Why? |
| Intensive Care Units | 1 | 2017 | 29594 | 0.01 | Why? |
| Aged, 80 and over | 1 | 2021 | 88759 | 0.01 | Why? |
| Spike Glycoprotein, Coronavirus | 1 | 2021 | 37182 | 0.01 | Why? |
| Risk Factors | 1 | 2018 | 71621 | 0.01 | Why? |
| Betacoronavirus | 1 | 2020 | 204454 | 0.00 | Why? |
Morélot-Panzini's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts
(165)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(146)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_